Get started
Author

Nienke J. de Boer‐Veger

Observed names: De Boer-Veger, Nienke J., Nienke J. de Boer-Veger, Nienke de Boer-Veger, de Boer-Veger, Nienke J, de Boer-Veger, Nienke J.
Institution: Martini Ziekenhuis
Observed institution: Martini Ziekenhuis
OpenAlex ID: A5005931895
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines
2019 · Carin A. T. C. Lunenburg, Cathelijne H. van der Wouden, et al. · European Journal of Human Genetics · 244
PDF
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics
2023 · Lianne Beunk, Marga Nijenhuis, et al. · European Journal of Human Genetics · 158
PDF
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs
2021 · Jurriaan M. J. L. Brouwer, Marga Nijenhuis, et al. · European Journal of Human Genetics · 135
PDF
Pharmacogenetic Information in Clinical Guidelines: The European Perspective
2018 · Jesse J. Swen, Marga Nijenhuis, et al. · Clinical Pharmacology & Therapeutics · 100
PDF
Dutch pharmacogenetics working group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan
2022 · Emma C. Hulshof, Maarten J. Deenen, et al. · European Journal of Human Genetics · 84
PDF
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)
2021 · Maja Matic, Marga Nijenhuis, et al. · European Journal of Human Genetics · 58
PDF
Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate
2022 · Karel H. van der Pol, Marga Nijenhuis, et al. · European Journal of Human Genetics · 38
PDF
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants
2024 · Lianne Beunk, Marga Nijenhuis, et al. · European Journal of Human Genetics · 27
PDF
Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate
2022 · Marga Nijenhuis, Bianca Soree, et al. · European Journal of Human Genetics · 27
PDF
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs
2024 · Lisanne E. N. Manson, Marga Nijenhuis, et al. · European Journal of Human Genetics · 24
PDF
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between SLCO1B1 and statins and CYP2C9 and sulfonylureas
2024 · David F. G. J. Wolthuis, Marga Nijenhuis, et al. · European Journal of Human Genetics · 14
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between TPMT/NUDT15 and thiopurines
2025 · Marieke J. H. Coenen, Marga Nijenhuis, et al. · European Journal of Human Genetics · 11
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and CYP2C19 and tricyclic antidepressants
2026 · Kristian Kleine Schaars, Marga Nijenhuis, et al. · European Journal of Human Genetics · 8
Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan
2023 · Emma C. Hulshof, Maarten J. Deenen, et al. · European Journal of Human Genetics · 7
PDF
Low-cost generation of clinical-grade, layperson-friendly pharmacogenetic passports using oligonucleotide arrays
2025 · Pauline Lanting, Robert Warmerdam, et al. · The American Journal of Human Genetics · 5
Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)
2021 · Maja Matic, Marga Nijenhuis, et al. · European Journal of Human Genetics · 5
PDF
Works count: 19
Citation count: 945
H-index: 11
I10-index: 12
Year
Topic
Type